logo
logo

Quidel Ortho Announces Changes In Executive Leadership

Feb 21, 2024over 1 year ago

Position

Chief Operating Officer

Company

QuidelOrtho Corporation

Robert Bujarski
San DiegoHealth DiagnosticsBiotechnologyHealth CareManufacturing

Description

The Board of Directors of QuidelOrtho Corporation has made significant decisions aimed to enhance operational efficiency, drive revenue growth and deliver shareholder value. The Board has terminated Douglas Bryant, President and Chief Executive Officer of QuidelOrtho, and appointed Michael Iskra as the Interim Chief Executive Officer, and Robert Bujarski as the Interim President, effective February 21, 2024.

Company Information

Company

QuidelOrtho Corporation

Location

San Diego, California, United States

About

QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day. Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence. Building upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects and a more informed path is illuminated for each of us.

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Related People

Brian hidden

hidden

Lee hidden

Michael hidden